These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30445600)

  • 1. TIPE1 promotes cervical cancer progression by repression of p53 acetylation and is associated with poor cervical cancer outcome.
    Zhao P; Pang X; Jiang J; Wang L; Zhu X; Yin Y; Zhai Q; Xiang X; Feng F; Xu W
    Carcinogenesis; 2019 Jun; 40(4):592-599. PubMed ID: 30445600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIPE1-mediated autophagy suppression promotes nasopharyngeal carcinoma cell proliferation via the AMPK/mTOR signalling pathway.
    Liu Y; Qi X; Zhao Z; Song D; Wang L; Zhai Q; Zhang X; Zhao P; Xiang X
    J Cell Mol Med; 2020 Aug; 24(16):9135-9144. PubMed ID: 32588529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
    Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
    Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner.
    Jiang J; Gao L; Lan Y; Wang Y; Zhao P
    Front Oncol; 2020; 10():593615. PubMed ID: 33520705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
    Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
    Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-587 promotes cervical cancer by repressing interferon regulatory factor 6.
    Ren Y; Dong J; He P; Liang Y; Wu L; Wang J; Chu B
    J Gene Med; 2020 Nov; 22(11):e3257. PubMed ID: 32749750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway.
    Xu J; Xu S; Fang Y; Chen T; Xie X; Lu W
    IUBMB Life; 2019 Mar; 71(3):347-356. PubMed ID: 30536701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
    J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel cytarabine analog evokes synthetic lethality by targeting MK2 in p53-deficient cancer cells.
    Song J; Yu J; Jeong LS; Lee SK
    Cancer Lett; 2021 Jan; 497():54-65. PubMed ID: 33075425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway.
    Wang J; Wu Y; Li Y; Wang Y; Shen F; Zhou J; Chen Y
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240/microRNA-124-3p/STAT3/MICA axis.
    Zhang Y; Li X; Zhang J; Liang H
    Cancer Lett; 2020 Apr; 474():63-73. PubMed ID: 31904481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIPE1 impairs stemness maintenance in colorectal cancer through directly targeting β-catenin.
    Ye T; Yang B; Wang C; Su C; Luo J; Yang X; Yu H; Yuan Z; Meng Z; Xia J
    Carcinogenesis; 2020 Mar; 41(1):25-35. PubMed ID: 31111874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNRPB promotes cervical cancer progression through repressing p53 expression.
    Zhu L; Zhang X; Sun Z
    Biomed Pharmacother; 2020 May; 125():109948. PubMed ID: 32106364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression.
    Cui N; Yang WT; Zheng PS
    Oncotarget; 2016 May; 7(18):26152-67. PubMed ID: 27036045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.
    Ma D; Fan SB; Hua N; Li GH; Chang Q; Liu X
    Curr Cancer Drug Targets; 2020; 20(5):355-363. PubMed ID: 31899677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2.
    Si W; Zhou B; Xie W; Li H; Li K; Li S; Deng W; Shi P; Yuan C; Ke T; Ren X; Tu X; Zeng X; Weigelt B; Rubin BP; Chen Q; Xu C; Wang QK
    Cancer Lett; 2021 Jan; 497():28-40. PubMed ID: 33069768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.